Robotic Liver Resection for Intrahepatic Cholangiocarcinoma: Perioperative and Oncologic Outcomes From a Single-Institution Experience
The American Surgeon™ · 2026-12 · 92 (12) · 3146-3153
DOI: 10.1177/00031348261455085 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Surgeon™, online erschienen am 26.05.2026. Verfasst von Garnet Vanterpool und 5 weiteren Autor:innen. Beteiligte Einrichtung: Digestive Health Institute, AdventHealth Tampa, Tampa, Florida, USA. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms, Robotic Surgical Procedures, Hepatectomy. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Background
Robotic liver resection (RLR) for intrahepatic cholangiocarcinoma (ICC) remains a newly adopted approach with limited data supporting its oncologic validity. We aimed to evaluate perioperative outcomes and early oncologic metrics following RLR for ICC at a single hepatobiliary center.
Methods
A retrospective analysis was conducted on patients undergoing RLR for histologically confirmed ICC between January 2018 and December 2024. Data were collected and analyzed using descriptive statistics.
Results
Thirty-five patients underwent RLR for ICC. Mean age was 69 years, with 66% male and a mean ASA grade of III. Major resections comprised 54% of cases, with no conversions to open surgery or intraoperative complications. Mean operative time was 321 years and mean estimated blood loss was 239 mL. R0 resection was achieved in 97% of cases. Mean lymph node harvested was 5, with 37% of patients having ≥6 nodes retrieved. Mean tumor size was 6 cm, with 94% of patients harboring tumors >2 cm and 60% staged as N0. Postoperative complication rate was 34%, with Clavien-Dindo ≥III at 14%. No reoperation occurred. 90-day mortality was 6%. Mean length of stay was 6 days. At a mean follow-up of 21 months, recurrence was observed in 25% of patients, with a mean disease-free survival of 17 months.
Conclusion
Robotic liver resection for ICC is safe and feasible, yielding high rates of R0 resection, low conversion and complication rates, with acceptable oncological outcomes. These findings support the continued integration of robotics in complex liver oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Digestive Health Institute, AdventHealth Tampa, Tampa, Florida, USA.
ORCID-Profile: Sharona B Ross, Iswanto Sucandy
Zitieren
APA
Vanterpool, G., Odorizzi, R., Ross, S. B., Zhang, H., Covilo, K. M., & Sucandy, I. (2026). Robotic Liver Resection for Intrahepatic Cholangiocarcinoma: Perioperative and Oncologic Outcomes From a Single-Institution Experience. The American Surgeon™, 92(12), 3146-3153. https://doi.org/10.1177/00031348261455085
Vancouver
Vanterpool G, Odorizzi R, Ross SB, Zhang H, Covilo KM, Sucandy I. Robotic Liver Resection for Intrahepatic Cholangiocarcinoma: Perioperative and Oncologic Outcomes From a Single-Institution Experience. The American Surgeon™. 2026;92(12):3146-3153. doi:10.1177/00031348261455085
BibTeX
@article{Vanterpool2026,
author = {Vanterpool, Garnet and Odorizzi, Roberta and Ross, Sharona B and Zhang, Henry and Covilo, Kristina Milivojev and Sucandy, Iswanto},
title = {Robotic Liver Resection for Intrahepatic Cholangiocarcinoma: Perioperative and Oncologic Outcomes From a Single-Institution Experience},
journal = {The American Surgeon™},
year = {2026},
volume = {92},
number = {12},
pages = {3146--3153},
doi = {10.1177/00031348261455085}
}
EUVIMED